Andreas Halvorsen - Viking Global Investors
Holding/activity history for Adaptive Biotechnologies Corp. (ADPT)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 29,993,708 | 1.16 | $13.88 | $416,312,667 | SEC | ||
| 2025 Q4 | 29,993,708 | 1.29 | $16.24 | $487,097,818 | SEC | ||
| 2025 Q3 | 29,993,708 | 1.17 | $14.96 | $448,705,872 | SEC | ||
| 2025 Q2 | 29,993,708 | 1.01 | $11.65 | $349,426,698 | SEC | ||
| 2025 Q1 | 29,993,708 | 0.71 | $7.43 | $222,853,250 | SEC | ||
| 2024 Q4 | 29,993,708 | 0.58 | $5.99 | $179,812,279 | SEC | ||
| 2024 Q3 | 29,993,708 | 0.56 | $5.12 | $153,567,785 | SEC | ||
| 2024 Q2 | 29,993,708 | 0.42 | $3.62 | $108,577,223 | SEC | ||
| 2024 Q1 | 29,993,708 | 0.36 | $3.21 | $96,279,803 | SEC | ||
| 2023 Q4 | 29,993,708 | 0.54 | $4.90 | $146,969,169 | SEC | ||
| 2023 Q3 | 29,993,708 | 0.67 | $5.45 | $163,465,709 | SEC | ||
| 2023 Q2 | 29,993,708 | 0.83 | $6.71 | $201,257,781 | SEC | ||
| 2023 Q1 | 29,993,708 | 1.25 | $8.83 | $264,844,442 | SEC | ||
| 2022 Q4 | 29,993,708 | 1.15 | $7.64 | $229,151,929 | SEC | ||
| 2022 Q3 | 29,993,708 | 0.99 | $7.12 | $213,555,000 | SEC | ||
| 2022 Q2 | 29,993,708 | 1.11 | $8.09 | $242,649,000 | SEC | ||
| 2022 Q1 | 29,993,708 | 1.69 | $13.88 | $416,313,000 | SEC | ||
| 2021 Q4 | 29,993,708 | 2.44 | $28.06 | $841,623,000 | SEC | ||
| 2021 Q3 | 29,993,708 | 2.82 | $33.99 | $1,019,486,000 | SEC | ||
| 2021 Q2 | 29,993,708 | 3.72 | $40.86 | $1,225,543,000 | SEC | ||
| 2021 Q1 | 29,993,708 | 3.60 | $40.26 | $1,207,547,000 | SEC | ||
| 2020 Q4 | 29,993,708 | 4.89 | Reduce 10.45% | 0.62 | $59.13 | $1,773,528,000 | SEC |
| 2020 Q3 | 33,493,708 | 5.89 | $48.63 | $1,628,799,000 | SEC | ||
| 2020 Q2 | 33,493,708 | 7.00 | $48.38 | $1,620,426,000 | SEC | ||
| 2020 Q1 | 33,493,708 | 4.84 | Reduce 12.79% | 0.69 | $27.78 | $930,455,000 | SEC |
| 2019 Q4 | 38,406,607 | 5.38 | $29.92 | $1,149,126,000 | SEC | ||
| 2019 Q3 | 38,406,607 | 6.18 | $30.90 | $1,186,764,000 | SEC | ||
| 2019 Q2 | 38,406,607 | 8.32 | Buy | 8.32 | $48.30 | $1,855,039,000 | SEC |